[1]
Campagna, J. et al. 2022. Identification of a Papain-Like Protease Inhibitor with Potential for Repurposing in Combination with an Mpro Protease Inhibitor for Treatment of SARS-CoV-2. Archives of Clinical and Biomedical Research. 6, 6 (Dec. 2022), 993–1002.